Olumiant Baricitinib 4mg Tablets ₹ 7000 / Box Get Latest Price Product Brochure Strength / Dose 4 mg Packaging Type Strip Packaging Size 7 Tablets Brand Olumiant Manufacturer Lilly Olumiant 4mg Tablet is a Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage. Olumiant 4mg Tablet is a Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage. Olumiant 4mg Tablet can be taken with or without food, but it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you take. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could worsen. The most common side effects of Olumiant 4mg Tablet include throat and nose infections, nausea, and viral infection. You may also get cold sores, a feeling of sickness, or have symptoms of a cold like stuffy nose, sneezing, and sore throat. There are other less common side effects, some serious, including blood clots and tears in the stomach or intestine wall. These need urgent medical attention. If you have concerns regarding side effects, talk to your doctor. You may need blood tests before you are given this medicine, and you should not start taking it if you have any infection. Make sure you talk to your doctor before starting treatment if you have or have ever had tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Olumiant 4mg Tablet can make you more likely to get infections or worsen any current infections, so avoid contact with people who have things you might catch (e.g., chickenpox, measles, or flu). This medicine is not suitable for children under 18 years old, and you should not use it if you’re pregnant or breastfeeding unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you regularly.

Myhep Lvir Ledipasvir And Sofosbuvir Tablets ₹ 4999 / Bottle Get Latest Price Product Brochure Strength 90mg/400mg Quantity Per Pack 28 Tabs Manufactured By MYLAN PHARMACEUTICALS PVT LTD Item Name Myhep Lvir Trade Name Myhep Lvir Usage Chronic Hepatitis C virus infection. Country of Origin Made in India Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection. This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Myhep Lvir Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment. Talk to your doctor immediately before taking this drug if you have diabetes. You may need closer monitoring of your blood glucose levels or adjustment of your diabetes medication after starting this drug. Some diabetic patients have experienced low sugar levels in the blood (hypoglycemia) after starting treatment with medicines like Myhep Lvir Tablet. The doctor will test your blood before, during, and after your treatment with this medicine. So that your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus, do not breastfeed during treatment with this tablet. It is unknown whether this drug passes into human breast milk. Consult your doctor if you are breastfeeding. Do not give this tablet to children under three years of age. The use of this drug has not yet been studied. This tablet can interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions. Uses of Myhep Lvir Tablet Chronic Hepatitis C virus infection

Hepcinat plus tablet contains active agents Daclatasvir and Sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Hepcinat plus tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus. Hepatitis B virus reactivation can cause serious liver problems and liver failure. It is vital to inform your doctor if you are taking or have taken any medication for heart problems in the past months. Elderly patients may be more susceptible to the side effects of Hepcinat plus tablet and may require lower doses or closer monitoring during treatment. The safety and effectiveness of pediatric patients have not been established. These medications should only be used in children under the guidance of a pediatric specialist.

Taficita tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body. Do not take Taficita tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under.

Trioday tablet contains the active substance called efavirenz, lamivudine, tenofovir disoproxil Fumarate. Efavirenz is an antiretroviral family in the class of medications called non nucleoside reverse transcriptase inhibitors (NNRTIs). Lamivudine and tenofovir disoproxil Fumarate is an antiretroviral or antiviral medicine belonging to the class of medications called nucleotide reverse transcriptase inhibitors (NRTI). Do not take trioday tablet if you are allergic to efavirenz, lamivudine, tenofovir disoproxil fumarate, or its other medical ingredients. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During this treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications. Report to your doctor if you have or had a history of heart failure (QT prolongation), seizures, mental health issues, pancreatitis (inflammation in the pancreas), bone disease (osteonecrosis - the death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems. Inform your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not recommended while taking a this tablet, due to the potential transmission of HIV from the mother to the baby.

Kocitaf Tablet contains the active ingredient Kocitaf Tablet. It is a combination of antiretroviral medication. Dolutegravir belongs to a class of antiretroviral drugs called integrase strand transfer inhibitors (INSTIs). Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is combined with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age who weigh at least 35kg. The combination is available as a single tablet regimen, simplifying treatment by reducing the number of pills a person must take daily. This convenience improves medication adherence, ensuring individuals can consistently take their prescribed medication as scheduled. Do not take Kocitaf Tablet if anyone is allergic to it or its components. Get tested for HIV infection regularly while using this medicine. Missing a dose increases the risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Patients should inform the physician if they have liver problems or liver disease, including hepatitis, kidney, and bone problems. This medication is not recommended to give in to children aged 11 years or under.

Pain Killer Tapentadol Tablets ₹ 799 / Box Get Latest Price Product Brochure Strength 100 mg Packing 1 x 10 Available strength 50mg,100mg,150mg,200mg,225mg Brand Tapaday 100mg Country of Origin Made in India Tapentadol is a strong painkiller which is used in the treatment of moderate to severe pain when other treatments do not treat your pain well enough or you cannot tolerate them. The addiction / habit-forming potential of Tapentadol is very high. Take exactly as prescribed by your doctor. Use caution while driving or doing anything that requires concentration as Tapentadol can cause dizziness and sleepiness. While taking this medication, avoid alcohol in all forms including beer, wine, aftershave lotions, mouthwash, vinegar, certain desserts, colognes, and liquid medications. Inform your doctor if you have asthma, liver, kidney or pancreatic disease, or are severely constipated.

Oral Semaglutide Tablets For Weight Loss 3mg 7mg 14mg Tablets Get Best Quote Request Callback ₹ 3149 / Pack Get Latest Price Product Brochure Form Tablets Packaging Type Box Composition Semaglutide Packaging Size 1 X 10 Brand RYBELSUS Manufacturer NOVO NORDISK Shelf Life 24 Months Usuage to treat type 2 diabetes Prescription / Non Prescription Prescription Usage WEIGHT LOSS RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is not known if RYBELSUS® can be used in people who have had pancreatitis RYBELSUS® is not for use in people with type 1 diabetes It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age Key takeaways: Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name. Yes! I am interested Rybelsus Semaglutide 3Mg 7Mg 14Mg Tablets Get Best Quote Request Callback ₹ 2900 / Stripe Get Latest Price Product Brochure Form Tablets Packaging size 10*10 Tablets Packaging Type Strip Composition Semaglutide Brand Rybelsus Shelf Life 24 Months Usuage to treat type 2 diabetes Prescription / Non Prescription Prescription strength 3 mg RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is not known if RYBELSUS® can be used in people who have had pancreatitis RYBELSUS® is not for use in people with type 1 diabetes It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age Key takeaways: Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name. Yes! I am interested Victoza Liraglutide Injection Get Best Quote Request Callback ₹ 4800 / Piece Get Latest Price Product Brochure Strength 6 mg/ ml Packaging Type Vial Brand Victozoa Usage / Application Personal Shelf Life 24 Months Country of Origin Made in India Liraglutide injection (Victoza) is used with a diet and exercise program to control blood sugar levels in adults and children 10 years of age and older with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) when other medications Yes! I am interested BEMPIFY 180MG 100 TAB BEMPEDOIC ACID Get Best Quote Request Callback ₹ 100 / Stripe Get Latest Price Product Brochure Packaging Size 10*10 Tablets Packaging Type Stripe Strength 180 mg Brand BEMPIFY 180MG Country of Origin Made in India Bempify Tablet 180mg is used to lower cholesterol and reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, possibly leading to a heart attack or stroke. Yes! I am interested Mounjaro Tirzepatide 5mg/0.5ml Injection Get Best Quote Request Callback ₹ 5999 / Vial Get Latest Price Product Brochure Strength 5 mg Packaging Size 0.5 ml Packaging Type Injection Brand Maunjaro Manufacturer Eli Lilly and Company India Pvt Ltd Prescription No Usage / Application Management of Obesity Mounjaro 5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite. Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the me

₹ 2999 / Piece Get Latest Price Product Brochure Strength 125 mcg Packaging Type Box Composition Fluticasone Furoate + Umeclidinium + Vilanterol Brand Trelegy Ellipta Manufacturer GSK Prescription/Non prescription Non prescription Shelf Life 2 Years Country of Origin Made in India Trelegy Ellipta Powder For Inhalation is used in the treatment of chronic obstructive pulmonary disorder (COPD), a lung disorder in which the flow of air to the lung is blocked. It provides relief from COPD symptoms like wheezing, shortness of breath, coughing, and chest tightness. This medicine is for inhalation purposes only. Thus, it should not be taken by mouth. It is important to follow all the guidelines of the doctor before using it. Before using the medicine, the doctor will guide you on how to use this medicine. Use it in the dose and duration advised by the doctor. Common cold is the most common side effect of this medicine. You may also experience side effects like fungal infection of the mouth, infection of the nose, blocked nose, cough, and headache. If any of these side effects persist or get worse, you should let your doctor know. Do not use this medicine without consulting the doctor if you have any problems related to heart, liver, or if you have glaucoma, tuberculosis (TB), asthma, and enlarged prostate.USES OF TRELEGY ELLIPTA INHALER Chronic obstructive pulmonary disease (COPD) BENEFITS OF TRELEGY ELLIPTA INHALERIn Chronic obstructive pulmonary disease (COPD)Trelegy Ellipta Powder For Inhalation helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.SIDE EFFECTS OF TRELEGY ELLIPTA INHALERMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Trelegy Ellipta Common cold Fungal infection of mouth Nasal congestion (stuffy nose) Inflammation of the nose Bronchitis (inflammation of the airways) Upper respiratory tract infection Headache Cough Hoarseness of voice HOW TO USE TRELEGY ELLIPTA INHALERCheck the label for directions before use. Shake the inhaler. While you are breathing in from mouth, press down on the inhaler one time to release the medication and hold your breath for 10 seconds. Repeat until you have inhaled the number of puffs as suggested by the doctor.Afterwards, rinse your mouth thoroughly with water and spit it out.HOW TRELEGY ELLIPTA INHALER WORKSTrelegy Ellipta Powder For Inhalation is a combination of fluticasone furoate, umeclidinium, and vilanterol. Fluticasone Furoate works by blocking the production of certain chemicals in the body that cause inflammation (redness and swelling) and allergies. Umeclidinium and vilanterol work by relaxing air passages in the lungs, making breathing easier